BioCentury
ARTICLE | Company News

Zosano, Eli Lilly deal

December 8, 2014 8:00 AM UTC

Zosano granted Eli Lilly exclusive, worldwide rights to commercialize osteoporosis product ZP-PTH. Lilly will make an equity investment of up to $15 million in Zosano concurrent with Zosano’s IPO. Zos...